Summary & Overview
HCPCS A9292: Prescription Digital Visual Therapy, Software-Only
HCPCS Level II code A9292 represents a prescription digital visual therapy application that is software-only and FDA cleared, billed per course of treatment. As digital therapeutics expand across clinical specialties, this code standardizes reporting for a non-device, software-based vision therapy delivered over a defined treatment course. Nationally, adoption of software-based prescriptions affects coverage policies, prior authorization practices, and alignment with telehealth and digital health frameworks.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code signifies, common billing considerations, and the payer landscape. The publication outlines benchmarks and typical sites of service, summarizes clinical context for prescription digital visual therapy, and highlights policy topics payers and providers are likely to address when integrating FDA-cleared therapeutic software into care pathways.
This resource is intended for billing managers, payers, clinicians, and health policy stakeholders seeking concise, national-level context about HCPCS Level II code A9292, how it is used to report software-only visual therapy per course of treatment, and the policy and operational issues relevant to its uptake.
Billing Code Overview
HCPCS Level II code A9292 describes prescription digital visual therapy, software-only, FDA cleared, per course of treatment. This service represents a prescribed software-based therapeutic intervention intended to treat visual conditions through a defined course of therapy.
-
Service type: Prescription digital visual therapy (software-only)
-
Typical site of service: Outpatient or home-based digital therapy delivered via patient-owned or provider-provided devices; software is prescribed and accessed remotely or in clinic settings
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adolescent or adult with convergence insufficiency, accommodative dysfunction, or binocular vision disorders who is prescribed an FDA-cleared, software-only, prescription digital visual therapy program for a defined course of treatment. The patient has an evaluation by an optometrist or ophthalmologist documenting symptoms (e.g., diplopia, eye strain, difficulty reading) and baseline clinical measures (near point of convergence, positive fusional vergence, accommodative amplitude). The clinician documents medical necessity, selects the appropriate digital therapy regimen, issues a prescription for the software-only product billed as A9292 per course of treatment, and provides instructions for home or supervised use.
The clinical workflow: the provider performs a diagnostic eye examination, documents the binocular vision diagnosis and treatment plan, prescribes the FDA-cleared software program, and arranges patient access (license key or portal enrollment). The patient completes the prescribed sessions (often daily or several times weekly) over the specified course; progress is monitored by follow-up visits or remote data review. Billing for the software-only prescription uses A9292 once per course of therapy; professional services (evaluation, follow-up) are billed separately using appropriate evaluation and management or ophthalmology/optometry codes and may include modifier 26 when only the professional component is billed or one of the modifiers related to multiple practitioners or technical component responsibilities where applicable.
Coding Specifications
| Modifier | Description |
|---|